Keyphrases
Hospital Admission
100%
Selective Screening
100%
Methicillin-resistant Staphylococcus Aureus
100%
Infection Averted
100%
Admission Screening
100%
PCR-based
75%
Universal Screening
50%
Media-based
50%
Health Benefits
25%
Cost-benefit
25%
Cost Savings
25%
Test Cost
25%
Nosocomial Infection
25%
Clinical High Risk
25%
Long-term Health
25%
Simulation Model
25%
Background Screening
25%
Cost-effective Strategy
25%
PCR Screening
25%
Methicillin-resistant Staphylococcus Aureus Infection
25%
Long-term Costs
25%
US Health Care
25%
Financial Benefits
25%
Carer Perspectives
25%
Infection Diagnosis
25%
Screening Cost
25%
Medicine and Dentistry
Health Care Cost
100%
Methicillin Resistant Staphylococcus Aureus
100%
Infection
55%
Polymerase Chain Reaction
55%
Prevalence
44%
Hospital Infection
11%
Methicillin Resistant Staphylococcus Aureus Infection
11%
Nursing and Health Professions
Infection
100%
Methicillin-Resistant Staphylococcus Aureus
100%
Prevalence
80%
Cost Control
40%
Hospital Infection
20%
Methicillin Resistant Staphylococcus Aureus Infection
20%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Methicillin-Resistant Staphylococcus Aureus
100%
Prevalence
80%
Hospital Infection
20%
Methicillin Resistant Staphylococcus Aureus Infection
20%
Immunology and Microbiology
Polymerase Chain Reaction
100%
Methicillin-Resistant Staphylococcus Aureus
100%
Prevalence
80%
Biochemistry, Genetics and Molecular Biology
Polymerase Chain Reaction
100%
Methicillin Resistant Staphylococcus Aureus
100%
Prevalence
80%